147 related articles for article (PubMed ID: 38875461)
1. Bone health in patients with inflammatory bowel disease.
Kreienbuehl AS; Rogler G; Emanuel B; Biedermann L; Meier C; Juillerat P; Restellini S; Hruz P; Vavricka SR; Aeberli D; Seibold F
Swiss Med Wkly; 2024 Jun; 154():3407. PubMed ID: 38875461
[TBL] [Abstract][Full Text] [Related]
2. Updated bone mineral density status in Saudi patients with inflammatory bowel disease.
Ewid M; Al Mutiri N; Al Omar K; Shamsan AN; Rathore AA; Saquib N; Salaas A; Al Sarraj O; Nasri Y; Attal A; Tawfiq A; Sherif H
World J Gastroenterol; 2020 Sep; 26(35):5343-5353. PubMed ID: 32994692
[TBL] [Abstract][Full Text] [Related]
3. Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease.
Stokkers PC; Deley M; Van Der Spek M; Verberne HJ; Van Deventer SJ; Hommes DW
Scand J Gastroenterol; 2006 Feb; 41(2):200-4. PubMed ID: 16484125
[TBL] [Abstract][Full Text] [Related]
4. Prevention and treatment of osteoporosis in inflammatory bowel disease.
Lichtenstein GR; Sands BE; Pazianas M
Inflamm Bowel Dis; 2006 Aug; 12(8):797-813. PubMed ID: 16917235
[TBL] [Abstract][Full Text] [Related]
5. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
[TBL] [Abstract][Full Text] [Related]
6. Milk and dairy product consumption in patients with inflammatory bowel disease: Helpful or harmful to bone mineral density?
Krela-Kaźmierczak I; Michalak M; Szymczak-Tomczak A; Czarnywojtek A; Wawrzyniak A; Łykowska-Szuber L; Stawczyk-Eder K; Dobrowolska A; Eder P
Nutrition; 2020; 79-80():110830. PubMed ID: 32563771
[TBL] [Abstract][Full Text] [Related]
7. A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America.
Soybilgic A; Tesher M; Wagner-Weiner L; Onel KB
Pediatr Rheumatol Online J; 2014; 12():24. PubMed ID: 25053923
[TBL] [Abstract][Full Text] [Related]
8. Clinical Course of Bone Metabolism Disorders in Patients with Inflammatory Bowel Disease: A 5-Year Prospective Study.
Casals-Seoane F; Chaparro M; Maté J; Gisbert JP
Inflamm Bowel Dis; 2016 Aug; 22(8):1929-36. PubMed ID: 27135482
[TBL] [Abstract][Full Text] [Related]
9. [Osteoporosis associated with inflammatory bowel diseases].
Miheller P; Tóth M; Pregun I; Tulassay Z
Orv Hetil; 2004 May; 145(20):1045-51. PubMed ID: 15202326
[TBL] [Abstract][Full Text] [Related]
10. Metabolic bone disease in inflammatory bowel disease.
Harpavat M; Keljo DJ; Regueiro MD
J Clin Gastroenterol; 2004 Mar; 38(3):218-24. PubMed ID: 15128066
[TBL] [Abstract][Full Text] [Related]
11. Basic and clinical aspects of osteoporosis in inflammatory bowel disease.
Rodríguez-Bores L; Barahona-Garrido J; Yamamoto-Furusho JK
World J Gastroenterol; 2007 Dec; 13(46):6156-65. PubMed ID: 18069754
[TBL] [Abstract][Full Text] [Related]
12. Osteopenia and osteoporosis in patients with new diagnosis of inflammatory bowel disease.
Adriani A; Pantaleoni S; Luchino M; Ribaldone DG; Reggiani S; Sapone N; Sguazzini C; Isaia G; Pellicano R; Astegiano M
Panminerva Med; 2014 Jun; 56(2):145-9. PubMed ID: 24994578
[TBL] [Abstract][Full Text] [Related]
13. Perspectives on osteoporosis in pediatric inflammatory bowel disease.
Harpavat M; Keljo DJ
Curr Gastroenterol Rep; 2003 Jun; 5(3):225-32. PubMed ID: 12734045
[TBL] [Abstract][Full Text] [Related]
14. Physical activity is associated with improved bone health in children with inflammatory bowel disease.
Vanhelst J; Vidal F; Turck D; Drumez E; Djeddi D; Devouge E; Spyckerelle C; Zandzou SG; Legrand C; Michaud L; Béghin L; Gottrand F; Coopman S; Ley D
Clin Nutr; 2020 Jun; 39(6):1793-1798. PubMed ID: 31427183
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patients.
Krajcovicova A; Hlavaty T; Killinger Z; Miznerova E; Toth J; Letkovsky J; Nevidanska M; Cierny D; Koller T; Zelinkova Z; Huorka M; Payer J
J Crohns Colitis; 2014 Dec; 8(12):1693-701. PubMed ID: 25175812
[TBL] [Abstract][Full Text] [Related]
16. Prescription drug therapies for prevention and treatment of postmenopausal osteoporosis.
O'Connell MB
J Manag Care Pharm; 2006 Jul; 12(6 Suppl A):S10-9; quiz S26-8. PubMed ID: 17269853
[TBL] [Abstract][Full Text] [Related]
17. Examination, prevention and treatment of osteoporosis in patients with inflammatory bowel disease: recommendations and reality.
Kirchgatterer A; Wenzl HH; Aschl G; Hinterreiter M; Stadler B; Hinterleitner TA; Petritsch W; Knoflach P
Acta Med Austriaca; 2002; 29(4):120-3. PubMed ID: 12424936
[TBL] [Abstract][Full Text] [Related]
18. Weekly oral bisphosphonates over 2 years prevent bone loss in cardiac transplant patients.
Lange U; Classen K; Müller-Ladner U; Richter M
Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28940569
[TBL] [Abstract][Full Text] [Related]
19. Bone health in inflammatory bowel disease.
Wei H; Zhao Y; Xiang L
Expert Rev Gastroenterol Hepatol; 2023; 17(9):921-935. PubMed ID: 37589220
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor (VDR) TaqI polymorphism, vitamin D and bone mineral density in patients with inflammatory bowel diseases.
Szymczak-Tomczak A; Krela-Kaźmierczak I; Kaczmarek-Ryś M; Hryhorowicz S; Stawczyk-Eder K; Szalata M; Skrzypczak-Zielińska M; Łykowska-Szuber L; Eder P; Michalak M; Dobrowolska A; Słomski R
Adv Clin Exp Med; 2019 Jul; 28(7):955-960. PubMed ID: 30929318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
